NDC 73293-0001-01 - Lidocaine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73293-0001
- Requested NDC
- 73293-0001-01
- Package NDCs from labels
- 73293-0001-1, 73293-0001-2, 73293-0001-01
- Manufacturer
- Huons Co., Ltd.
- Effective date
- 2025-05-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lidocaine Hydrochloride Injection USP For Infiltration and Nerve Block Rx only | Huons Co., Ltd. | 2025-05-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73293-0001-1 | Lidocaine Hydrochloride | 5 mL in 1 VIAL | SOLUTION | 5 | 11 | |
| 73293-0001-2 | Lidocaine Hydrochloride | 10 in 1 BOX | SOLUTION | 10 | 11 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 73293-0001 | LIDOCAINE HYDROCHLORIDE SOLUTION [HUONS CO., LTD.] | 10 | Current NDC, Legacy NDC, 2 package rows | 20240328_8ec2d256-fc4f-44f6-bee2-eef2bf3bf580.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 73293-0001-1 | ML - Milliliter | 73293-0001 | 57bf1da6-d5a4-42d3-82dc-1d6082a5a2c2 | 1 | 2021-11-09 |
| 73293-0001-2 | ML - Milliliter | 73293-0001 | 4e672423-fb35-4983-8464-f42173fdab52 | 1 | 2022-12-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Numquick Analgesic | EPINEPHRINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE | Unit Dose, Ltd. | b66e7a91-9e35-64dd-e053-2a95a90a8b83 | 2024-02-28 | Warnings | V13007Z41A |
| Lidotral 3.88% Roll on | LIDOCAINE HCI | PureTek Corporation | db1085fe-0a1f-c4cc-e053-2a95a90aa838 | 2024-02-28 | Warnings, Adverse reactions | V13007Z41A |
| EPST PLUS | CARDUUS MARIANUS, CISTUS CANADENSIS, DULCAMARA, GALIUM APARINE, MAGNESIA MURIATICA, NATRUM SULPHURICUM, VISCUM ALBUM, MURIATICUM ACIDUM, FOLLICULINUM, AQUA MARINA, AILANTHUS GLANDULOSUS, BARYTA MURIATICA, CADMIUM METALLICUM, CEANOTHUS AMERICANUS, COCCULUS INDICUS, IRIDIUM METALLICUM, THUJA OCCIDENTALIS, CINCHONA OFFICINALIS, CALCAREA CARBONICA, CROTALUS CASCAVELLA | Deseret Biologicals, Inc. | c2bb50a8-e4f9-4af4-aefc-53c9c3cfcc25 | 2024-02-27 | Warnings | 451W47IQ8X QTT17582CB |
| LIDOCAINE HCI AND EPINEPHRINE | LIDOCAINE HCI AND EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | 957506a5-1b09-0736-e053-2995a90a0b63 | 2024-02-26 | Warnings, Adverse reactions | V13007Z41A |
| SunBurnt PLUS | LIDOCAINE HYDROCHLORIDE | Quest Products, LLC. | 12128c75-015d-8a72-e063-6394a90ae00a | 2024-02-23 | Warnings | V13007Z41A |
| LIDOCAINE HCl AND EPINEPHRINE | LIDOCAINE HCL AND EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | a098ab6c-143f-77a5-e053-2a95a90a3e0a | 2024-02-22 | Warnings, Adverse reactions | V13007Z41A |
| Kroger Analgesic Analgesic | LIDOCAINE HYDROCHLORIDE | THE KROGER CO | e6c5ead3-87d0-48ed-a4dc-86cf89ebb285 | 2024-02-22 | Warnings | V13007Z41A |
| GI Drainage | CINNAMOMUM, GENTIANA LUTEA, SYZYGIUM JAMBOLANUM, ARGENTUM NITRICUM, COLCHICUM AUTUMNALE, COLOSTRUM (BOVINE), COPPER GLUCONATE, LAPPA MAJOR, LYCOPODIUM CLAVATUM, MAGNESIUM GLUCONICUM, MANGANESE GLUCONATE, PANCREAS SUIS, POTASSIUM GLUCONATE, RUMEX CRISPUS, STOMACH (SUIS), AURUM METALLICUM, CALCAREA CARBONICA, CARBO VEGETABILIS, INTESTINE (SUIS), MALUS PUMILA, FLOS, NITRICUM ACIDUM, PRUNUS CERASIFERA, FLOS, ROCK WATER, SCHROPHULARIA NODOSA, FAGUS SYLVATICA, FLOS | Deseret Biologicals, Inc. | ff81e3ca-2f88-4daf-a734-083107269d3a | 2024-02-21 | Warnings | 059QF0KO0R |
| LIDOCAINE HCl | LIDOCAINE HCL | HF Acquisition Co LLC, DBA HealthFirst | c1735498-0721-687c-e053-2a95a90a47f4 | 2024-02-19 | Warnings, Adverse reactions | V13007Z41A |
| 1168 | 1168 BURN SPRAY | Dynarex Corporation | 1183a4f5-f875-dfb0-e063-6394a90af35f | 2024-02-16 | Warnings | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | 0050d05a-b8e9-c544-e063-6294a90a0243 | 2024-02-08 | Boxed warning, Warnings, Adverse reactions | V13007Z41A |
| Bladder Relief | CAUSTICUM, NATRUM MURIATICUM, NUX VOMICA, PULSATILLA (VULGARIS), SEPIA, STAPHYSAGRIA, THUJA OCCIDENTALIS | The Magni Company | b09bf037-703f-4c22-8535-b33d586ebefa | 2024-02-08 | Warnings | 451W47IQ8X |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Safetec of America, Inc. | 1c5eb3b3-79b3-472a-ae36-ec6a7dc72925 | 2024-02-07 | Warnings | V13007Z41A |
| Antiseptic | ALCOHOL, LIDOCAINE HYDROCHLORIDE | Safetec of America, Inc. | 71aeaf86-2b4d-4945-9606-a9db0ab6b726 | 2024-02-07 | Warnings | V13007Z41A |
| First Aid and Burn | BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE | Safetec of America, Inc. | 47cb6921-5d82-4123-a9e0-0b05d4dcb5b2 | 2024-02-07 | Warnings | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Safetec of America, Inc. | 8eb3e7e2-26e5-430e-89aa-40a0367c637e | 2024-02-07 | Warnings | V13007Z41A |
| Sterile Water | STERILE WATER | Chartwell RX, LLC | 3681eeaa-807a-47ca-9fbc-61c2b682800a | 2024-02-01 | 059QF0KO0R | |
| Sterile Water | WATER | A-S Medication Solutions | dba87371-31d2-47c2-ab83-89aabce4b184 | 2024-01-31 | Warnings, Adverse reactions | 059QF0KO0R |
| Mirakel Pain Relief Roll-On | LIDOCAINE HCL | Sanvio, Inc. | 102f3618-13ad-37e3-e063-6294a90a8086 | 2024-01-30 | Warnings | V13007Z41A |
| Natrum Muriaticum | SODIUM CHLORIDE | SEVENE USA | 11008014-fff6-4d5a-8c5c-a20443d7cc23 | 2024-01-30 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.